Abstract
Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Current Medicinal Chemistry
Title: Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Volume: 18 Issue: 4
Author(s): G. Portella, C. Passaro and P. Chieffi
Affiliation:
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Abstract: Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Export Options
About this article
Cite this article as:
Portella G., Passaro C. and Chieffi P., Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer, Current Medicinal Chemistry 2011; 18 (4) . https://dx.doi.org/10.2174/092986711794480203
DOI https://dx.doi.org/10.2174/092986711794480203 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Niche for Acridine Derivatives in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
Current Topics in Medicinal Chemistry Modulation of Inflammatory Immune Reactions by Low-Dose Ionizing Radiation: Molecular Mechanisms and Clinical Application
Current Medicinal Chemistry Old Drugs-Current Perspectives
Current Pharmacogenomics PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy
Current Drug Delivery Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets New Framework for the Discovery of PRC2 Inhibitors: Epigenetic Drugs
Current Drug Targets Cytotoxic and Apoptogenic Activity of a Methanolic Extract from the Marine Invertebrate Ciona intestinalis on Malignant Cell Lines
Medicinal Chemistry Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Cancer Drug Targets Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Current Drug Targets Medical Chemistry to Spy Cancer Stem Cells from Outside the Body
Mini-Reviews in Medicinal Chemistry Cyclophosphamide: Time to Say Goodnight and Goodbye?
Current Rheumatology Reviews Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress
Current Drug Metabolism